The Use of DPP-4 Inhibitors in Short Bowel Syndrome

NCT02653131 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped too many side-effects

Conditions

Short Bowel Syndrome

Interventions

DRUG: Dipeptidyl peptidase-4 inhibitor

Sponsor

Stanley Dudrick's Memorial Hospital